Key result
Central venous catheters in cancer patients are associated with high rates of deep venous thrombosis and pulmonary embolism, warranting prophylaxis and long-term anticoagulant therapy.
Why the study?
Does prophylaxis and long-term anticoagulant therapy prevent thrombotic complications in cancer patients with central venous catheters?
Population
Cancer patients with indwelling long-term central venous catheters
Design
Review
Authors
Loading...
May support prophylaxis consideration in cancer patients with central venous catheters; leaves open confirmation from randomized trials.
Does prophylaxis and long-term anticoagulant therapy prevent thrombotic complications in cancer patients with central venous catheters?
Cancer patients with central venous catheters are at high risk for catheter-related DVT and subsequent pulmonary embolism, warranting consideration of prophylaxis and long-term anticoagulation.
Monreal et al. (2001) conducted a review in Cancer with central venous catheters. Central venous catheters was evaluated. Central venous catheters in cancer patients are associated with high rates of deep venous thrombosis and pulmonary embolism, warranting prophylaxis and long-term anticoagulant therapy.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: